URB754
From Self-sufficiency
Revision as of 16:56, 30 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): cannabinoid-stub)
| URB754 | |
|---|---|
| File:URB754.svg | |
| 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 86672-58-4 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
URB754 was originally reported to be a potent, noncompetitive inhibitor of monoacylglycerol lipase.[1] However, recent studies have shown that URB754 failed to inhibit recombinant MGL, and brain FAAH activity was also resistant to URB754.[2] Some controversy in the field remains regarding the use of this compound.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40px | This article about a cannabinoid is a stub. You can help ssf by expanding it. |
- ↑ Makara JK, Mor M, Fegley D, Szabó SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D (2005). "Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus". Nat. Neurosci. 8 (9): 1139–41. doi:10.1038/nn1521. PMID 16116451.
- ↑ Saario SM, Palomäki V, Lehtonen M, Nevalainen T, Järvinen T, Laitinen JT (2006). "URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain". Chem. Biol. 13 (8): 811–4. doi:10.1016/j.chembiol.2006.07.008. PMID 16931330.
